1999
DOI: 10.1034/j.1398-9995.1999.00987.x
|View full text |Cite
|
Sign up to set email alerts
|

Phenytoin hypersensitivity syndrome with fatal evolution

Abstract: were made at 48 and 96 h according to the ICDRG (International Contact Dermatitis Research Group) guidelines. The results are shown in Table 1. The positive reactions to wool alcohols, fragrance mix, colophony, and balsam of Peru had past relevance, but the positive reaction to black rubber mix did not. Six weeks later, we retested the patient with PG (0.5%, 1% and 2% aq.) showing positive results at D2 with PG 1% and 2% aq. We also performed a ROAT (repeated open application test) with PG 2% aq. (two applicat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0
2

Year Published

2001
2001
2016
2016

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 4 publications
0
3
0
2
Order By: Relevance
“…The phenytoin hypersensitivity syndrome is characterized by maculopapular rash and exfoliative dermatitis, high fever, hepatic failure, lymphadenopathy and leucocytosis with eosinophilia, typically developing within 3–6 weeks from the start of treatment 1–4,10 , 11 . In our patient, the characteristic reactions developed 25 days after the patient was started on phenytoin.…”
Section: Discussionmentioning
confidence: 68%
“…The phenytoin hypersensitivity syndrome is characterized by maculopapular rash and exfoliative dermatitis, high fever, hepatic failure, lymphadenopathy and leucocytosis with eosinophilia, typically developing within 3–6 weeks from the start of treatment 1–4,10 , 11 . In our patient, the characteristic reactions developed 25 days after the patient was started on phenytoin.…”
Section: Discussionmentioning
confidence: 68%
“…TO THE EDITOR: Anticonvulsant hypersensitivity syndrome (AHS) is an idiosyncratic reaction to aromatic anticonvulsants that can result in severe multiorgan dysfunction and death. 1,2 To our knowledge, this is the first report of a fatal case of AHS in a pediatric patient in Taiwan.…”
mentioning
confidence: 80%
“…However, its true incidence is unknown due to variable presentations, lack of consensus regarding a standardised name and inaccurate reporting. This rare adverse event can result in death 3 …”
Section: Commentmentioning
confidence: 99%